Latest News about DRMA
Recent news which mentions DRMA
Why Avaya Holdings Shares Are Trading Lower By 62%? Here Are 62 Stocks Moving In Friday's Mid-Day Session
December 16, 2022
From Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
December 16, 2022
From Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
December 05, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Monday
December 05, 2022
From Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
November 15, 2022
From Benzinga
From Benzinga
Why Vaxcyte Shares Are Trading Sharply Higher? Here Are 63 Stocks Moving In Monday's Mid-Day Session
October 24, 2022
From Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
September 21, 2022
From Benzinga
Why Allena Pharmaceuticals Tumbled Over 30%; Here Are 85 Biggest Movers From Yesterday
September 07, 2022
From Benzinga
Why Hill International Shares Are Trading Higher By 58%: Here Are 25 Stocks Moving Premarket
August 17, 2022
From Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
August 16, 2022
From Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
August 01, 2022
From Benzinga
From Benzinga
Why This Biotechnology Surged More Than 60%; Here Are 67 Biggest Movers From Yesterday
July 27, 2022
From Benzinga
From Benzinga
Tesla, Twitter And 76 Biggest Movers From Friday
July 11, 2022
From Benzinga
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Why Is Akebia Therapeutics Surging By 28%? 48 Stocks Moving In Friday's Mid-Day Session
July 01, 2022
From Benzinga
From Benzinga
From InvestorPlace
Akebia Therapeutics And 20 Stocks Moving Premarket
July 01, 2022
From Benzinga
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.